Evidence map›Paper›PMID 29198724›Full record

ArticleAmerican journal of human genetics2017

Monoallelic BMP2 Variants Predicted to Result in Haploinsufficiency Cause Craniofacial, Skeletal, and Cardiac Features Overlapping Those of 20p12 Deletions.

Tiong Yang Tan, Claudia Gonzaga-Jauregui, Elizabeth J Bhoj, Kevin A Strauss, Karlla Brigatti, Erik Puffenberger, Dong Li, LiQin Xie, Nanditha Das, Ioanna Skubas and 25 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Association BetweenIndian journal of orthopaedics · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 11 institutions in 5 countries.

Tiong Yang TanVictorian Clinical Genetics Services, Melbourne, VIC 3052, Australia; Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia. Electronic address: tiong.tan@vcgs.org.au.
Claudia Gonzaga-JaureguiRegeneron Genetics Center, Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Elizabeth J BhojCenter for Applied Genomics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4399, USA.
Kevin A StraussClinic for Special Children, Philadelphia, PA 17579, USA.
Karlla BrigattiClinic for Special Children, Philadelphia, PA 17579, USA.
Erik PuffenbergerClinic for Special Children, Philadelphia, PA 17579, USA.
Dong LiCenter for Applied Genomics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4399, USA.
LiQin XieRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Nanditha DasRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Ioanna SkubasRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Ron A DeckelbaumRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Virginia HughesRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Susannah BrydgesRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Sarah HatsellRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Chia-Jen SiaoRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Melissa G DominguezRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Aris EconomidesRegeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
John D OvertonRegeneron Genetics Center, Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Valerie MayneRoyal Children's Hospital, Parkville, Melbourne, VIC 3052, Australia.
Peter J SimmMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia; Royal Children's Hospital, Parkville, Melbourne, VIC 3052, Australia.
Bryn O JonesMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Royal Children's Hospital, Parkville, Melbourne, VIC 3052, Australia.
Stefanie EggersMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia.
Gwenaël Le GuyaderDepartment of Medical Genetics, Poitiers University Hospital, Poitiers 86021, France.
Fanny PelluardDepartment of Pathology, Bordeaux University Hospital, Bordeaux 33076, France.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, 72076 Tuebingen, Germany.
Marc SturmInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, 72076 Tuebingen, Germany.
Angelika RiessInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, 72076 Tuebingen, Germany.
Stephan WaldmuellerInstitute of Medical Genetics and Applied Genomics, University of Tuebingen, 72076 Tuebingen, Germany; Universitätsklinik für Kinder- und Jugendmedizin, Kinderheilkunde II Kardiologie Intensivmedizin Pulmologie, 72076 Tuebingen, Germany.
Michael HofbeckUniversitätsklinik für Kinder- und Jugendmedizin, Kinderheilkunde II Kardiologie Intensivmedizin Pulmologie, 72076 Tuebingen, Germany.
Katharina SteindlInstitute of Medical Genetics, University of Zurich, 8952 Schlieren-Zurich, Switzerland.
Pascal JosetInstitute of Medical Genetics, University of Zurich, 8952 Schlieren-Zurich, Switzerland.
Anita RauchInstitute of Medical Genetics, University of Zurich, 8952 Schlieren-Zurich, Switzerland.
Hakon HakonarsonCenter for Applied Genomics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4399, USA.
Naomi L BakerMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia.
Peter G FarlieMurdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia.
Regeneron (United States) · USChildren's Hospital of Philadelphia · USClinic for Special Children · USRoyal Children's Hospital · AUThe University of Melbourne · AUUniversity of Tübingen · DEUniversity of Zurich · CHZentrum für Kinderheilkunde · DEMurdoch Children's Research Institute · AUUniversité de Bordeaux · FRUniversité de Poitiers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone morphogenetic protein 2 (BMP2) in chromosomal region 20p12 belongs to a gene superfamily encoding TGF-β-signaling proteins involved in bone and cartilage biology. Monoallelic deletions of 20p12 are variably associated with cleft palate, short stature, and developmental delay. Here, we report a cranioskeletal phenotype due to monoallelic truncating and frameshift BMP2 variants and deletions in 12 individuals from eight unrelated families that share features of short stature, a recognizable craniofacial gestalt, skeletal anomalies, and congenital heart disease. De novo occurrence and autosomal-dominant inheritance of variants, including paternal mosaicism in two affected sisters who inherited a BMP2 splice-altering variant, were observed across all reported families. Additionally, we observed similarity to the human phenotype of short stature and skeletal anomalies in a heterozygous Bmp2-knockout mouse model, suggesting that haploinsufficiency of BMP2 could be the primary phenotypic determinant in individuals with predicted truncating variants and deletions encompassing BMP2. These findings demonstrate the important role of BMP2 in human craniofacial, skeletal, and cardiac development and confirm that individuals heterozygous for BMP2 truncating sequence variants or deletions display a consistent distinct phenotype characterized by short stature and skeletal and cardiac anomalies without neurological deficits.

Indexed as

AnimalsBone and BonesBone Morphogenetic Protein 2ChildChild, PreschoolChromosomes, Human, Pair 20Cleft PalateCraniofacial AbnormalitiesDevelopmental DisabilitiesDisease Models, AnimalDwarfismFemaleHaploinsufficiencyHeartHeart Defects, CongenitalHumansBMP2 protein, humanBone Morphogenetic Protein 2Transforming Growth Factor betabonebone morphogenetic proteinscongenital heart diseasecraniofacialskeleton

Identifiers

PMID29198724
PMCPMC5812889
OpenAlexW2771238835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.